van Houte Hans — SEC Form 4 filings

SEC reporting owner CIK 1817217. 26 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2024-01-30 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nurix Therapeutics, Inc. (NRIX)Chief Financial Officer2629 legs · 129,352 sh · $2,302,52374

Form 4 filings — van Houte Hans

FiledFormIssuerReported transactionsSource
2026-08-044Nurix Therapeutics, Inc. (NRIX)Sale (S): 1,794 @ $23.89 · Sale (S): 2,967 @ $24.65EDGAR
2026-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Option exercise (M): 3,572 @ $0 · Sale (S): 2,845 @ $23.38 · Option exercise (M): 3,750 (derivative) @ $0 · Option exercise (M): 2,858 (derivative) @ $0 · +1 moreEDGAR
2026-05-054Nurix Therapeutics, Inc. (NRIX)Sale (S): 13,473 @ $16.58 · Sale (S): 582 @ $17.18EDGAR
2026-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 2,388 @ $16.65 · Option exercise (M): 2,000 (derivative) @ $0 · Option exercise (M): 3,750 (derivative) @ $0 · +1 moreEDGAR
2026-02-104Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 42,875 (derivative) @ $0EDGAR
2026-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,887 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,859 @ $0 · Sale (S): 3,588 @ $16.58 · Sale (S): 73 @ $17.37 · +4 moreEDGAR
2025-11-034Nurix Therapeutics, Inc. (NRIX)Sale (S): 6,284 @ $12.56EDGAR
2025-10-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 3,130 @ $12.80 · Option exercise (M): 2,886 (derivative) @ $0 · +3 moreEDGAR
2025-08-014Nurix Therapeutics, Inc. (NRIX)Sale (S): 5,402 @ $11.03EDGAR
2025-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Option exercise (M): 2,858 @ $0 · Sale (S): 4,304 @ $12.01 · Option exercise (M): 2,886 (derivative) @ $0 · +3 moreEDGAR
2025-05-024Nurix Therapeutics, Inc. (NRIX)Sale (S): 6,198 @ $11.33EDGAR
2025-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,438 @ $11.50 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2025-03-034Nurix Therapeutics, Inc. (NRIX)Sale (S): 5,125 @ $14.40 · Sale (S): 700 @ $15.13EDGAR
2025-02-134Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 75,000 (derivative) @ $0 · Grant/award (A): 34,300 (derivative) @ $0EDGAR
2025-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,557 @ $19.81 · Sale (S): 254 @ $20.33 · Option exercise (M): 2,886 (derivative) @ $0 · +2 moreEDGAR
2024-11-014Nurix Therapeutics, Inc. (NRIX)Sale (S): 3,546 @ $24.28EDGAR
2024-10-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,368 @ $24.30 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2024-08-264Nurix Therapeutics, Inc. (NRIX)Sale (S): 20,000 @ $25.22EDGAR
2024-08-014Nurix Therapeutics, Inc. (NRIX)Sale (S): 3,377 @ $21.43 · Sale (S): 100 @ $22.22EDGAR
2024-07-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Option exercise (M): 3,750 @ $0 · Sale (S): 2,490 @ $20.67 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0 · +1 moreEDGAR
2024-06-204Nurix Therapeutics, Inc. (NRIX)Sale (S): 20,000 @ $20.01EDGAR
2024-05-024Nurix Therapeutics, Inc. (NRIX)Sale (S): 3,499 @ $12.83EDGAR
2024-04-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,387 @ $12.04 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2024-02-164Nurix Therapeutics, Inc. (NRIX)Sale (S): 6,812 @ $10.02EDGAR
2024-02-154Nurix Therapeutics, Inc. (NRIX)Grant/award (A): 150,000 (derivative) @ $0 · Grant/award (A): 45,000 (derivative) @ $0EDGAR
2024-01-304Nurix Therapeutics, Inc. (NRIX)Option exercise (M): 2,886 @ $0 · Option exercise (M): 2,000 @ $0 · Sale (S): 1,671 @ $7.99 · Option exercise (M): 2,886 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1817217 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →